In case you missed it: August 22 to August 26
A look back at the week's top headlines.
FDA grants emergency use of Novavax COVID-19 vaccine, adjuvanted in patients 12 years and older
Novavax joins the growing list of COVID-19 vaccines including vaccines from Pfizer-BioNTech, Moderna, and Johnson & Johnson’s Janssen
FDA expands approval of Mirena for up to 8 years
After a recent FDA approval, Mirena can be used to prevent pregnancy for up to 8 years.
Gestational diabetes mellitus rate increased from 2016 to 2020
Data from the US Department of Health and Human Services has shown an increase in GDM rate from 2016 to 2020, with a greater increase observed from 2019 to 2020.
March of Dimes launches new preterm birth research center at UCSF
Marina Sirota, PhD, associate professor of pediatrics at the University of California, San Francisco, spoke about the new March of Dimes Prematurity Research Center at UCSF and the impact they hope their research will have on the future of preterm birth.
Short menstrual cycles may predict earlier menopause, worse symptoms in midlife
Women with shorter menstrual cycles may reach menopause earlier and experience more severe symptoms overall, according to research in Menopause.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
